knowledge -WSS

knowledge

author：focus 2025-09-02 08:25:27 - browse：8

President Joe Biden talks in the Roosevelt Room of the White House, in front of a painting of Theodore Roosevelt on a horse back — politics coverage from STAT — President Biden MANDEL NGAN/AFP via Getty Images

WASHINGTON — The White House is throwing its support behind a controversial authority that allows the government to undermine patent rights for certain high-priced medicines. It’s an early step that could have major ramifications for the American pharmaceutical industry, depending on whether and how federal officials actually use the authority.

The administration issued a framework for the National Institutes of Health to more broadly use so-called “march-in rights” — a policy that allows it to invalidate patent rights from drugmakers whose products rely on federally funded research. The framework lays out when the agency might assert this authority, and endorse using a drug’s price in that determination.

“We’ll make clear that when drug companies won’t sell taxpayer funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House National Economic Advisor Lael Brainard told reporters. “These authorities are in existing laws, the last administration just didn’t want to allow them to be used in this way.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Can Threads overtake X, formerly known as Twitter? Experts weigh in.

hotspot

WSS

Warren pushes Witty on UnitedHealth's control over physicians

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Judge rejects Trump's counterclaim against E. Jean Carroll

AltruBio raises $225 million to develop ulcerative colitis drug

Black vets could get higher VA benefits if race not used in lung test

CDC launches VaccineFinder tool to locate Covid

Wikipedia

knowledge

focus

Wildfire smoke exposes gaps in outdoor worker protections

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Apple is now the first public company to be valued at $3 trillion

Former Georgia lieutenant governor says he received grand jury subpoena

The high cost of giving birth even with insurance

Hospitals use virtual reality to design more inclusive rooms for kids

Medicare proposal to cover medical devices draws a mixed reaction

Judge rejects Trump's counterclaim against E. Jean Carroll

Anesthesiologist group: stop taking Ozempic before surgery

GSK’s asthma push continues as drug succeeds in Phase 3 trials

leisure time

Travel bans should be based on evidence, not politics or fear

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Deliver public health messages at the right time

Discs beat pads, tampons for heavy menstrual flow, new study shows

Brain technologies pose threats that are all too real, experts warn

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

entertainment

Wikipedia

hotspot

focus